Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Authors
Keywords
Liver fibrosis, Diabetes, NAFLD, Inflammation, Cirrhosis, Hepatocellular carcinoma
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 176, Issue -, Pages 113888
Publisher
Elsevier BV
Online
2021-07-24
DOI
10.1016/j.addr.2021.113888
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient l-amino acid-defined diet-induced murine model
- (2021) Yoon Mee Yang et al. ARCHIVES OF PHARMACAL RESEARCH
- How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
- (2021) Yana Geng et al. Hepatology International
- Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis
- (2021) Masaaki Sagara et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
- (2021) Dakota R. Kamm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis
- (2021) Eline Geervliet et al. JOURNAL OF CONTROLLED RELEASE
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Regulation of intestinal lipid metabolism: current concepts and relevance to disease
- (2020) Chih-Wei Ko et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
- (2020) Petra Hirsova et al. Cell Death & Disease
- Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
- (2020) Frank Jühling et al. GUT
- Genetics of diabetes mellitus and diabetes complications
- (2020) Joanne B. Cole et al. Nature Reviews Nephrology
- TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
- (2020) Franziska Wandrer et al. Cell Death & Disease
- Mitochondrial oxidative injury: A key player in nonalcoholic fatty liver disease
- (2020) Waleska Dornas et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease
- (2020) Alexandra Chadt et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Obesity-Linked PPARγ S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3
- (2020) Jessica A. Hall et al. Cell Metabolism
- Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
- (2020) Carolyn F. Deacon Nature Reviews Endocrinology
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
- (2020) Evangelia Makri et al. ARCHIVES OF MEDICAL RESEARCH
- APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease
- (2020) Qing-Yang Xu et al. Biomed Research International
- FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
- (2020) Emma Henriksson et al. Frontiers in Endocrinology
- Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
- (2019) Daniel Garcia et al. Cell Reports
- Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease
- (2019) Francisco Javier Cubero et al. Cell Death & Disease
- Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis
- (2019) Jessica Maiers et al. SEMINARS IN LIVER DISEASE
- Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
- (2019) Zhijin chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
- (2019) Hyuk Moon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis
- (2019) Jingwen Luo et al. ACS Nano
- Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways
- (2019) Reham M. Essam et al. LIFE SCIENCES
- Recent advances in synthetic pharmacotherapies for dyslipidaemias
- (2019) Cesare R Sirtori et al. European Journal of Preventive Cardiology
- Understanding Contemporary Use of Thiazolidinediones
- (2019) Suzanne V. Arnold et al. Circulation-Heart Failure
- An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
- (2019) Yanping Li et al. JOURNAL OF CONTROLLED RELEASE
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
- (2019) Yoon Mee Yang et al. Science Translational Medicine
- Molecular tuning of farnesoid X receptor partial agonism
- (2019) Daniel Merk et al. Nature Communications
- Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
- (2019) Wenhao Li et al. Acta Pharmaceutica Sinica B
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
- (2019) Leanne Hodson et al. Nature Reviews Endocrinology
- Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
- (2019) Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
- (2019) Anitha Krishnan et al. Journal of Neuroinflammation
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy
- (2019) Qian-Qian Fan et al. BIOMATERIALS
- Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies
- (2019) Fei Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
- (2019) Quentin M. Anstee et al. Contemporary Clinical Trials
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- 4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization
- (2019) Irina N. Andreichenko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
- (2019) Guadalupe Garcia-Tsao et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
- (2019) Jarren R. Oates et al. Frontiers in Immunology
- MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
- (2018) Qiaozhu Su et al. ADVANCED DRUG DELIVERY REVIEWS
- Battle of GLP-1 delivery technologies
- (2018) Minzhi Yu et al. ADVANCED DRUG DELIVERY REVIEWS
- Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways
- (2018) Xueqing Zhong et al. BIOMEDICINE & PHARMACOTHERAPY
- Interleukin-37 Treatment of Mice with Metabolic Syndrome Improves Insulin Sensitivity and Reduces Pro-inflammatory Cytokine Production in Adipose Tissue
- (2018) Dov B Ballak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis
- (2018) Jian-Bin Qiao et al. JOURNAL OF CONTROLLED RELEASE
- To die or not to die: death signaling in nonalcoholic fatty liver disease
- (2018) Yuko Akazawa et al. JOURNAL OF GASTROENTEROLOGY
- Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms
- (2018) Cen Guo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents
- (2018) Dongke Yu et al. LIVER INTERNATIONAL
- Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis
- (2018) Astrid Ruiz-Margáin et al. LIVER TRANSPLANTATION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway
- (2018) Hong Yao et al. PHARMACOLOGICAL RESEARCH
- Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
- (2018) Daniela Carmen Oniciu et al. PLoS One
- Apoptosis and non-alcoholic fatty liver diseases
- (2018) Tatsuo Kanda et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development
- (2018) Zachary J. Brown et al. Cell Death & Disease
- Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study
- (2018) Martine C. Morrison et al. Frontiers in Physiology
- TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
- (2018) Yuqiao Sheng et al. Frontiers in Immunology
- Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
- (2018) Mohammad Zarei et al. Molecular Metabolism
- AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
- (2018) Nadia Boudaba et al. EBioMedicine
- Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
- (2018) Ryan M. Esquejo et al. EBioMedicine
- Adipocyte-Derived Exosomes Carrying Sonic Hedgehog Mediate M1 Macrophage Polarization-Induced Insulin Resistance via Ptch and PI3K Pathways
- (2018) Ming Song et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
- (2018) Zhigang Ren et al. GUT
- PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling
- (2018) Brandon M. Gassaway et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant
- (2018) Michelle Khai Khun Yap et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione-based fibrates as potential hypolipidemic and hepatoprotective agents
- (2018) Zi-Zhang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor
- (2018) Yi Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sonic hedgehog signaling instigates high-fat diet-induced insulin resistance by targeting PPARγ stability
- (2018) Qinyu Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design of Hedgehog pathway inhibitors for cancer treatment
- (2018) Jitender Bariwal et al. MEDICINAL RESEARCH REVIEWS
- Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
- (2018) Edgar D. Charles et al. Obesity
- BET Inhibition Improves NASH and Liver Fibrosis
- (2018) Sarah A. Middleton et al. Scientific Reports
- Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis
- (2018) Raffaella Maria Gadaleta et al. Scientific Reports
- FOX01 Is the Headline Akt Regulating Hepatic Glucose Metabolism
- (2017) Greg C Smith et al. ENDOCRINOLOGY
- Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease
- (2017) Malek Yaghoubi et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
- (2017) David N. Assis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
- (2017) Mukul R. Jain et al. LIVER INTERNATIONAL
- A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
- (2017) Stuart McPherson et al. PLoS One
- Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
- (2017) Sabina Yasmin et al. Scientific Reports
- Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse
- (2017) Ádám Horváth et al. Scientific Reports
- Hedgehog signaling via Gli2 prevents obesity induced by high-fat diet in adult mice
- (2017) Yu Shi et al. eLife
- Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice
- (2016) Feng Li et al. BIOMATERIALS
- Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
- (2016) Virender Kumar et al. BIOMATERIALS
- Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
- (2016) Xiaobo Wang et al. Cell Metabolism
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Gut Microbiota and Lifestyle Interventions in NAFLD
- (2016) David Houghton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
- (2016) Varman T. Samuel et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients
- (2016) Evan Stein et al. Journal of Clinical Lipidology
- Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
- (2016) Yi-Nan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver
- (2016) Aki Yamada et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice
- (2016) Rinku Dutta et al. PHARMACEUTICAL RESEARCH
- Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with 99mTc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice
- (2016) Deliang Zhang et al. Scientific Reports
- Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
- (2016) Hans-Theo Schon et al. Frontiers in Pharmacology
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
- (2015) Zhengping Zhang et al. ACS Nano
- Hyaluronic acid–tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis
- (2015) Jeong-A Yang et al. Acta Biomaterialia
- DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling
- (2015) Thomas Oliver Eichmann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The TZD insulin sensitizer clue provides a new route into diabetes drug discovery
- (2015) Jerry R. Colca Expert Opinion on Drug Discovery
- Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease
- (2015) Hyunjoo Kwon et al. HEPATOLOGY
- Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
- (2015) Mariana Verdelho Machado et al. JOURNAL OF HEPATOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression
- (2015) Masashi Miyao et al. LABORATORY INVESTIGATION
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- Synthesis, binding affinity and structure–activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists
- (2015) Anna Junker et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- BRD4 is a novel therapeutic target for liver fibrosis
- (2015) Ning Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension
- (2015) Hien T. T. Duong et al. Small
- 68Ga-DOTA-Siglec-9 – a new imaging tool to detect synovitis
- (2015) Helena Virtanen et al. ARTHRITIS RESEARCH & THERAPY
- The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
- (2015) James Crane et al. Therapeutic Advances in Chronic Disease
- Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo
- (2015) Vladislav V. Glinsky et al. NEOPLASIA
- Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix
- (2014) Alessandro Parodi et al. ACS Nano
- Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
- (2014) Limei Wang et al. BIOCHEMICAL PHARMACOLOGY
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- Lack of Efficacy of an Inhibitor of PDE4 in Phase 1 and 2 Trials of Patients With Nonalcoholic Steatohepatitis
- (2014) Vlad Ratziu et al. Clinical Gastroenterology and Hepatology
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Ballooned hepatocytes, undead cells, sonic hedgehog, and Vitamin E: Therapeutic implications for nonalcoholic steatohepatitis
- (2014) Petra Hirsova et al. HEPATOLOGY
- Deletion of the Collagen-specific Molecular Chaperone Hsp47 Causes Endoplasmic Reticulum Stress-mediated Apoptosis of Hepatic Stellate Cells
- (2014) Kunito Kawasaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Delivery and Targeting of miRNAs for Treating Liver Fibrosis
- (2014) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- (2014) Y. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- Clinical Proof-of-Concept Study With MSDC-0160, a Prototype mTOT-Modulating Insulin Sensitizer
- (2013) J R Colca et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles
- (2013) M. Rajan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular Mechanism of Peroxisome Proliferator-Activated Receptor α Activation by WY14643: a New Mode of Ligand Recognition and Receptor Stabilization
- (2013) Amanda Bernardes et al. JOURNAL OF MOLECULAR BIOLOGY
- A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
- (2013) Sihao Liu et al. NATURE
- Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
- (2013) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
- (2013) Alexei Kharitonenkov et al. PLoS One
- The Chemokine CCL3 Promotes Experimental Liver Fibrosis in Mice
- (2013) Daniel Heinrichs et al. PLoS One
- Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis
- (2013) Dian J. Chiang et al. PLoS One
- Correction: Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo
- (2013) Julia Reetz et al. PLoS One
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
- (2013) Peter G. Traber et al. PLoS One
- The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1)
- (2012) Jonathan S. Foot et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
- (2012) K. D. Copps et al. DIABETOLOGIA
- Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione
- (2012) Zhouji Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Production of TNF- in Macrophages Activated by T Cells, Compared with Lipopolysaccharide, Uses Distinct IL-10-Dependent Regulatory Mechanism
- (2012) G. Agbanoma et al. JOURNAL OF IMMUNOLOGY
- Oxymatrine liposome attenuates hepatic fibrosisviatargeting hepatic stellate cells
- (2012) Ning-Li Chai WORLD JOURNAL OF GASTROENTEROLOGY
- Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis
- (2011) Kitae Park et al. BIOMATERIALS
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
- (2011) Mary Beth DeYoung et al. Diabetes Technology & Therapeutics
- Investigational A3adenosine receptor targeting agents
- (2011) Balázs Koscsó et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
- (2011) Claudia O. Zein et al. HEPATOLOGY
- The contribution of endoplasmic reticulum stress to liver diseases
- (2011) Lily Dara et al. HEPATOLOGY
- A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
- (2011) Vlad Ratziu et al. HEPATOLOGY
- CXCR3 ligands: redundant, collaborative and antagonistic functions
- (2011) Joanna R Groom et al. IMMUNOLOGY AND CELL BIOLOGY
- C-C Chemokine Receptor 2 Inhibitor Improves Diet-Induced Development of Insulin Resistance and Hepatic Steatosis in Mice
- (2011) Yukinori Tamura et al. Journal of Atherosclerosis and Thrombosis
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor–beta on hepatic fibrosis in rats
- (2011) Feng Li et al. JOURNAL OF CONTROLLED RELEASE
- A formulation‐enabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeys
- (2011) Po‐Chang Chiang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice
- (2011) M. M. van Beuge et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Elevated Hedgehog/Gli signaling causes -cell dedifferentiation in mice
- (2011) L. Landsman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
- (2011) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice
- (2011) Sivasami Pulavendran et al. JOURNAL OF NANOBIOTECHNOLOGY
- Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors
- (2010) Fanny Lalloyer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by Bioconjugation
- (2010) Lin Zhu et al. BIOCONJUGATE CHEMISTRY
- Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier
- (2010) Jeong-Hun Kang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
- (2010) Jonathan Y. Bass et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells
- (2010) Hongwei He et al. HEPATOLOGY
- CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice
- (2010) Tomonori Aoyama et al. HEPATOLOGY
- Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- A Promoter Polymorphism in the Liver-specific Fatty Acid Transport Protein 5 is Associated with Features of the Metabolic Syndrome and Steatosis
- (2010) A. Auinger et al. HORMONE AND METABOLIC RESEARCH
- Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
- (2010) Carla Iacobini et al. JOURNAL OF HEPATOLOGY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily
- (2009) J. H. Best et al. DIABETIC MEDICINE
- SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
- (2009) O. Holz et al. EUROPEAN RESPIRATORY JOURNAL
- Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
- (2009) John McHutchison et al. GASTROENTEROLOGY
- Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
- (2009) Koji Fujita et al. HEPATOLOGY
- Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones
- (2009) Seong Hwan Hwahng et al. HEPATOLOGY
- Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis
- (2009) Rafal P. Witek et al. HEPATOLOGY
- Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
- (2009) Matteo Ricchi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Synthesis and Biological Evaluation of 2-Alkynyl-N6-methyl-5′-N-methylcarboxamidoadenosine Derivatives as Potent and Highly Selective Agonists for the Human Adenosine A3Receptor‡
- (2009) Rosaria Volpini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
- (2009) Brenton Flatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- 15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor / Agonist
- (2009) S. Naruhn et al. MOLECULAR PHARMACOLOGY
- Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
- (2009) Markus Feuerer et al. NATURE MEDICINE
- Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
- (2009) Linda M. Sanderson et al. PHYSIOLOGICAL GENOMICS
- PPARγ activation in adipocytes is sufficient for systemic insulin sensitization
- (2009) Shigeki Sugii et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
- (2008) Yukinori Tamura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- siRNA-Mediated Reduction of Inhibitor of Nuclear Factor- B Kinase Prevents Tumor Necrosis Factor- -Induced Insulin Resistance in Human Skeletal Muscle
- (2008) R. L. Austin et al. DIABETES
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Olmesartan Prevents Cardiovascular Injury and Hepatic Steatosis in Obesity and Diabetes, Accompanied by Apoptosis Signal Regulating Kinase-1 Inhibition
- (2008) Eiichiro Yamamoto et al. HYPERTENSION
- Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue
- (2008) Ayaka Ito et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver
- (2008) Nanao Horike et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis
- (2008) Feng Li et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury
- (2008) Angela Douglass et al. JOURNAL OF HEPATOLOGY
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started